drug · antibody
zimberelimab
Phase 2updated 5mo agoby $RCUS Arcus Biosciences, Inc.🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 12 investigational indications.
indications
indications
NSCLCColorectal Cancer
targets
Programmed cell death protein 1
all catalysts(0)
nothing on the calendar yet
Trials studying zimberelimab
- phase1A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
- phase2Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01
- phase3A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
- phase1A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- phase2A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
- phase2Switch Maintenance in Pancreatic
- phase2Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
- phase1Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that